http://bit.ly/z2KOKJ Last week, the maker of the widely used cancer drug Avastin, issued a warning that a counterfeit version of the drug was...
» More
http://bit.ly/z2KOKJ Last week, the maker of the widely used cancer drug Avastin, issued a warning that a counterfeit version of the drug was discovered in the United States. The announcement revived concerns among hospital officials, government regulators, doctors and patients about the growing threat of fake drugs. Read the full story on Cancerwise http://bit.ly/z2KOKJ
Upon learning of the notice, MD Anderson pharmacy staff examined their supply of Avastin and confirmed that none of the counterfeit drug was found on the main campus, or in the regional care centers. As an additional safety procedure, pharmacists contacted their wholesale provider and determined that none of tainted drug entered the supply chain that MD Anderson purchases from.
David Crowther, a clinical pharmacy specialist, said MD Anderson has stringent guidelines when purchasing drugs and a set of procedures in place which are initiated at the time of recalls or other manufacturer warnings.
